Therefore, we used JM1 cells transduced with the dominant negative IKZF1 construct (IK6) that is a product of the exon 4 to 7 deletion mutation of Ikzf1 commonly detected in B-ALL patients. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.